v3.25.4
Leases
 12 Months Ended
Dec. 31, 2025
Leases [Abstract]  
Leases Leases    
AbbVie's lease portfolio primarily consists of real estate properties, vehicles and equipment. The following table summarizes the amounts and location of operating and finance leases on the consolidated balance sheets:
as of December 31 (in millions)Balance sheet caption20252024
Assets
OperatingOther assets$737 $723 
FinanceProperty and equipment, net44 33 
Total lease assets$781 $756 
Liabilities
Operating
CurrentAccounts payable and accrued liabilities$194 $178 
NoncurrentOther long-term liabilities689 697 
Finance
CurrentCurrent portion of long-term debt and finance lease obligations19 17 
NoncurrentLong-term debt and finance lease obligations22 23 
Total lease liabilities$924 $915 
The following table summarizes the lease costs recognized in the consolidated statements of earnings:
years ended December 31 (in millions)202520242023
Operating lease cost$213 $196 $189 
Short-term lease cost75 65 28 
Variable lease cost104 86 88 
Total lease cost$392 $347 $305 
Sublease income and finance lease costs were insignificant in 2025, 2024 and 2023.
The following table presents the weighted-average remaining lease term and weighted-average discount rate for operating and finance leases:
years ended December 31202520242023
Weighted-average remaining lease term (years)
Operating677
Finance453
Weighted-average discount rate
Operating3.5 %3.3 %3.0 %
Finance4.3 %4.2 %3.6 %
The following table presents supplementary cash flow information regarding the company's leases:
years ended December 31 (in millions)202520242023
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases$230 $204 $214 
Right-of-use assets obtained in exchange for new operating lease liabilities212 159 173 
Finance lease cash flows were insignificant in 2025, 2024 and 2023.
The following table summarizes the future maturities of AbbVie's operating and finance lease liabilities as of December 31, 2025:
(in millions)Operating
leases		Finance
leases
Total(a)
2026$224 $21 $245 
2027187 11 198 
2028157 7 164 
2029133 3 136 
2030100 — 100 
Thereafter184 2 186 
Total lease payments985 44 1,029 
Less: Interest102 3 105 
Present value of lease liabilities$883 $41 $924 
(a)Lease payments recognized as part of lease liabilities for optional renewal periods are insignificant.
Leases Leases    
AbbVie's lease portfolio primarily consists of real estate properties, vehicles and equipment. The following table summarizes the amounts and location of operating and finance leases on the consolidated balance sheets:
as of December 31 (in millions)Balance sheet caption20252024
Assets
OperatingOther assets$737 $723 
FinanceProperty and equipment, net44 33 
Total lease assets$781 $756 
Liabilities
Operating
CurrentAccounts payable and accrued liabilities$194 $178 
NoncurrentOther long-term liabilities689 697 
Finance
CurrentCurrent portion of long-term debt and finance lease obligations19 17 
NoncurrentLong-term debt and finance lease obligations22 23 
Total lease liabilities$924 $915 
The following table summarizes the lease costs recognized in the consolidated statements of earnings:
years ended December 31 (in millions)202520242023
Operating lease cost$213 $196 $189 
Short-term lease cost75 65 28 
Variable lease cost104 86 88 
Total lease cost$392 $347 $305 
Sublease income and finance lease costs were insignificant in 2025, 2024 and 2023.
The following table presents the weighted-average remaining lease term and weighted-average discount rate for operating and finance leases:
years ended December 31202520242023
Weighted-average remaining lease term (years)
Operating677
Finance453
Weighted-average discount rate
Operating3.5 %3.3 %3.0 %
Finance4.3 %4.2 %3.6 %
The following table presents supplementary cash flow information regarding the company's leases:
years ended December 31 (in millions)202520242023
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases$230 $204 $214 
Right-of-use assets obtained in exchange for new operating lease liabilities212 159 173 
Finance lease cash flows were insignificant in 2025, 2024 and 2023.
The following table summarizes the future maturities of AbbVie's operating and finance lease liabilities as of December 31, 2025:
(in millions)Operating
leases		Finance
leases
Total(a)
2026$224 $21 $245 
2027187 11 198 
2028157 7 164 
2029133 3 136 
2030100 — 100 
Thereafter184 2 186 
Total lease payments985 44 1,029 
Less: Interest102 3 105 
Present value of lease liabilities$883 $41 $924 
(a)Lease payments recognized as part of lease liabilities for optional renewal periods are insignificant.